AbbVie vs Meta: Founders, CEOs and History
AbbVie was founded in 2013 by Abbott Laboratories (spin-off origin) and is led by Robert A. Michael. Meta was founded in 2004 by Mark Zuckerberg, Eduardo Saverin, Andrew McCollum and is led by Mark Zuckerberg.
Company facts
Founders
AbbVie
Abbott Laboratories (spin-off origin)
Abbott Laboratories was AbbVie's corporate predecessor. AbbVie's official launch materials describe the company as formed in 2013 following separation from Abbott. Richard A.
Meta
Mark Zuckerberg
Meta possesses arguably the most scrutinized, polarizing, and dramatized founding story of the 21st century, rooted entirely in the exclusive, intensely competitive dormitory culture of Harvard University and driven by an effective, socially awkward computer p…
Eduardo Saverin
Eduardo Saverin was a Facebook co-founder and the company's first chief financial officer, but his long-term story diverged sharply from the company he helped start.
Andrew McCollum
Andrew McCollum co-founded Facebook but left the company relatively early compared with Zuckerberg and Moskovitz. After Facebook, he continued in technology and entrepreneurship, including work connected to education and startup leadership.
Dustin Moskovitz
Dustin Moskovitz co-founded Facebook and served as a key early technical and operational leader before leaving in 2008 to co-found Asana.
Chris Hughes
Chris Hughes co-founded Facebook and later became known for his work in media, politics, and public policy after leaving the company.
CEOs and their tenures
AbbVie
- Richard A. Gonzalez2013–2024
Founding Chairman and Chief Executive Officer
Served as AbbVie's chief executive officer from its formation in 2013 through June 2024 and as executive chairman through June 2025.
Source - Robert A. Michael2024–present
Chairman and Chief Executive Officer
Became chief executive officer on July 1, 2024 and chairman on July 1, 2025. He previously led finance, commercial operations, and corporate strategy roles at AbbVie.
Source
Meta
- Mark Zuckerberg2004–present
Founder, Chairman and CEO
Zuckerberg sets product and capital priorities and controls the majority of shareholder voting power through Class B shares.
Source - Eduardo Saverin2004–2005
Co-Founder
Eduardo Saverin co-founded Facebook with Mark Zuckerberg while at Harvard in 2004, providing the initial seed funding and serving as the company's first CFO and business manager.
Source
Timeline: AbbVie and Meta side by side
2004Meta
Facebook launches at Harvard
Facebook launched on February 4, 2004, as a real-name student network. The product mattered because it made identity, campus trust and friend connections the core of the service before the company became a public social platform.
2007Meta
Ad platform becomes the business model
Facebook's advertising products turned user attention into a scalable commercial system. The shift mattered because the company could keep the consumer product free while charging marketers for measurable reach, targeting and conversion tools.
2012Meta
Instagram acquisition
Facebook agreed to acquire Instagram for about $1 billion in cash and stock. The deal mattered because Instagram was mobile-native at a moment when Facebook needed to prove it could survive the smartphone shift.
2012Meta
Facebook IPO
Facebook completed its initial public offering in May 2012, raising about $16 billion.
2013AbbVie
AbbVie Launches as an Independent Company
AbbVie launched after Abbott Laboratories separated its research-based pharmaceutical business and began NYSE trading under ABBV.
2014Meta
WhatsApp acquisition
Facebook announced a deal to acquire WhatsApp, adding a large private messaging network to a company still known mainly for public feeds.
2014Meta
Oculus acquisition
Facebook agreed to acquire Oculus VR for about $2 billion. The deal mattered because it gave the company a hardware and immersive-computing bet years before the Meta rebrand.
2015AbbVie
Pharmacyclics Acquisition Completed
AbbVie completed its acquisition of Pharmacyclics, adding Imbruvica and expanding its hematologic oncology business.
2019AbbVie
Skyrizi Receives Initial U.S. Approval
The FDA approved Skyrizi for adults with moderate to severe plaque psoriasis in April 2019.
2019AbbVie
Rinvoq Receives Initial U.S. Approval
The FDA approved Rinvoq for adults with moderate to severe rheumatoid arthritis in August 2019.
2020AbbVie
Allergan Acquisition Completed
AbbVie completed the Allergan acquisition, adding neuroscience, eye care, and Allergan Aesthetics products including Botox and Juvederm.
2021Meta
Facebook becomes Meta
Facebook changed its corporate name to Meta in 2021 to bring its apps and technologies under a new company brand.
2023AbbVie
U.S. Humira Biosimilar Competition Begins
Humira began facing U.S. biosimilar competition, and AbbVie reported a subsequent decline in Humira revenue.
2023Meta
Threads launch
Meta launched Threads in July 2023 and said the app passed 100 million sign-ups in its first five days. The launch mattered because Instagram distribution gave Meta a fast entry into real-time text conversation.
2024AbbVie
ImmunoGen Acquisition Completed
AbbVie completed its acquisition of ImmunoGen, adding Elahere and antibody-drug conjugate programs.
2024AbbVie
Robert A. Michael Becomes CEO
Robert A. Michael succeeded Richard A. Gonzalez as chief executive officer effective July 1, 2024.
2024AbbVie
Cerevel Therapeutics Acquisition Completed
AbbVie completed its acquisition of Cerevel Therapeutics, adding clinical-stage neuroscience programs.
2024Meta
$164.501B revenue
Meta reported $164.501 billion in FY2024 revenue and $62.360 billion in net income. The year mattered because AI-powered ad tools, Reels monetization and expense discipline restored confidence after the 2022 slowdown.
2025AbbVie
Robert A. Michael Becomes Chairman
Robert A. Michael added the chairman role effective July 1, 2025, when Richard A. Gonzalez retired from the board.
2025AbbVie
FY2025 Revenue Reaches $61.160 Billion
AbbVie reported FY2025 net revenue of $61.160 billion and net income of $4.226 billion.
2025Meta
$200.966B Revenue
Meta reported $200.966B in FY2025 revenue, $60.458B in net income, $83.276B in income from operations, and 78,865 employees at year-end.
2026AbbVie
Q1 2026 Revenue Reaches $15.002 Billion
AbbVie reported first-quarter 2026 net revenue of $15.002 billion, up 12.4 percent on a reported basis.
2026Meta
Q2 2026 revenue up 28%
Meta reported Q2 2026 revenue of $60.80B, up 28%, and net income of $15.85B, down 14%, after $2.40B of legal charges and $1.18B of severance from a May 2026 headcount reduction. It narrowed 2026 capex guidance to $130-145B.
Acquisitions
AbbVie
- ImmunoGen, Inc.2024$10.1B
- Cerevel Therapeutics2024$8.7B
- Allergan plc2020$63B
- Pharmacyclics, Inc.2015$21B
Meta
- Kustomer2022$1B
- CTRL-labs2019$500M
- WhatsApp2014$19B
- Oculus VR2014$2B
- Instagram2012$1B
Questions about AbbVie vs Meta
Who is the CEO of AbbVie Inc. and Meta Platforms, Inc.?
AbbVie Inc. is led by Robert A. Michael and Meta Platforms, Inc. is led by Mark Zuckerberg. Both serve as the top executive responsible for the company's strategy, operations, and financial performance.
When was AbbVie Inc. founded vs Meta Platforms, Inc.?
Meta Platforms, Inc. was founded in 2004 — 9 years before AbbVie Inc., which was founded in 2013. Meta Platforms, Inc.'s longer operating history gives it a deeper track record but also potentially more institutional inertia compared to the younger AbbVie Inc..
How many employees does AbbVie Inc. have compared to Meta Platforms, Inc.?
AbbVie Inc. employs approximately 57,000 people, while Meta Platforms, Inc. employs approximately 75,472. Meta Platforms, Inc. has the larger workforce at 75,472 employees, compared to AbbVie Inc.'s 57,000. A higher headcount does not necessarily imply greater efficiency — it often reflects differences in business model (e.g., manufacturing vs. software).
Where are AbbVie Inc. and Meta Platforms, Inc. headquartered?
Both AbbVie Inc. and Meta Platforms, Inc. are headquartered in United States, meaning they operate under the same primary regulatory and tax environment.
Who founded AbbVie Inc. and Meta Platforms, Inc.?
AbbVie Inc. was founded by Abbott Laboratories (spin-off origin). Meta Platforms, Inc. was founded by Mark Zuckerberg, Eduardo Saverin, Andrew McCollum, Dustin Moskovitz, Chris Hughes.
Which company has a longer operating history — AbbVie Inc. or Meta Platforms, Inc.?
Meta Platforms, Inc. has been operating for approximately 22 years, making it the more established of the two companies. AbbVie Inc. has been in operation for around 13 years. A longer operating history often signals greater institutional resilience and brand recognition, though it can also mean slower adaptation to new market conditions.
Figures come from each company's filings and the sources linked beside them. Amounts reported in another currency are shown in US dollars at an approximate rate and marked with ~. Back to the AbbVie vs Meta overview